TranScrip is a leading pharmaceutical consultancy providing specialist support in the development and lifecycle of biopharmaceutical products to pharma and biotech companies. We bring innovative solutions to clients’ global drug development needs. We deliver both strategic leadership and operational support, covering clinical, regulatory, drug safety and commercial from pre-clinical through to post-licensing. In the last decade, tranScrip has performed over £50m of innovative research, regulatory and post-licensing support to over 250 clients. We have been integral to regulatory submissions, bringing on average one-two products to the market each year across a wide range of therapeutic areas.